How Does D.H.E. 45 Work? Mechanism of Action Explained in Plain English

D.H.E. 45 (dihydroergotamine mesylate) has been treating migraines since 1946, but its exact mechanism of action is actually a subject of ongoing scientific interest. Here's the clearest explanation of how it works — in language that doesn't require a medical degree.

What Is an Ergot Alkaloid?

Dihydroergotamine belongs to the ergot alkaloid drug class. Ergot alkaloids are derived from a fungus called Claviceps purpurea that infects grain — historically responsible for a condition called St. Anthony's Fire (ergotism). Modern pharmaceutical ergot alkaloids like DHE are highly purified and precisely dosed, eliminating the toxicity of natural exposure while preserving the drug's therapeutic effects.

Dihydroergotamine (DHE) is ergotamine that has been "hydrogenated" (chemically modified by adding hydrogen atoms) at the 9,10 position. This modification reduces the side effect profile compared to ergotamine while maintaining effective antimigraine activity.

Which Receptors Does D.H.E. 45 Bind?

DHE has a broad receptor-binding profile — it is not as selective as triptans. It binds with high affinity to:

Serotonin (5-HT) receptors — Particularly 5-HT1Dα and 5-HT1Dβ; also 5-HT1A, 5-HT2A, and 5-HT2C subtypes.

Alpha-adrenergic receptors — Noradrenaline α2A, α2B, and α1 receptors. This contributes to its vasoconstrictive and venoconstrictive effects.

This multi-receptor activity is what distinguishes DHE from triptans (which are mainly 5-HT1B/1D selective) and explains why DHE works in some patients when triptans don't — and why it also has more systemic effects.

Theory 1: Blood Vessel Constriction

The older and simpler theory of how DHE works focuses on blood vessels. During a migraine attack, intracranial blood vessels — especially on the surface of the brain — are thought to dilate abnormally. DHE activates 5-HT1D receptors located on these blood vessels, causing them to constrict (narrow). This constriction is thought to relieve the throbbing pain of migraine.

DHE is particularly effective at constricting veins as well as arteries — which may explain why its headache relief is longer-lasting and has a lower recurrence rate than most triptans. Venous constriction reduces the volume of blood in the cranial cavity, further reducing headache intensity.

Theory 2: Blocking Neurogenic Inflammation

The more current understanding involves the trigeminal nerve system. During migraine, trigeminal nerve fibers release pro-inflammatory neuropeptides — including calcitonin gene-related peptide (CGRP), substance P, and neurokinin A — around the blood vessels in the meninges (the layers covering the brain). This process is called neurogenic inflammation and is believed to drive the pain and sensitization of migraine.

DHE activates 5-HT1D receptors on the presynaptic terminals of trigeminal nerve endings, inhibiting the release of these inflammatory neuropeptides. By reducing neurogenic inflammation, DHE treats migraine at both the vascular and neural level — which is likely why it's effective even in complex migraine presentations.

38,224+ patients found their medications in stock

38K+

Find D.H.E. 45 In Stock Today →

How Is DHE Different From Triptans?

Triptans (sumatriptan, rizatriptan, eletriptan, etc.) are selective 5-HT1B/1D agonists — they mainly target serotonin receptors on cranial blood vessels and trigeminal nerve terminals. DHE is much broader, binding to multiple serotonin receptor subtypes as well as alpha-adrenergic receptors. This broader activity gives DHE:

A longer duration of action (more sustained vasoconstriction).

Lower headache recurrence rate after treatment.

Effectiveness in some patients where triptans fail.

More systemic vasoconstriction, which creates more contraindications (cardiac, vascular).

How Quickly Does D.H.E. 45 Work?

The route of administration determines onset speed:

IV — Fastest; effects typically begin within minutes. Used for rapid relief in hospital settings.

IM or SC — Onset within 15–30 minutes. Appropriate for home use by patients experienced with self-injection.

Nasal spray — Somewhat slower than injection; onset 30–60 minutes. Bioavailability is lower due to nasal mucosa absorption.

For a complete overview of D.H.E. 45, see what is D.H.E. 45. To learn more about what side effects to watch for as a result of DHE's vasoconstrictive mechanism, see our D.H.E. 45 side effects guide.